The QualityStocks Daily Monday, Novemeber 11th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(GOVX) $3.1400 +61.03%

Premium Stock Alerts(HOVR) $0.4523 +55.97%

360 Wall Street(BTM) $2.6800 +54.02%

The QualityStocks Daily Stock List

GeoVax Labs (GOVX)

Wall Street Resources, QualityStocks, IRGnews Alert, Standout Stocks, MarketClub Analysis, MarketBeat, Premium Stock Alerts, InvestorPlace, Penny Performers, SmallCapVoice, Stock News Now, Stock Stars, Stockpalooza, BUYINS.NET, SmallCapStockPlays, HotOTC, FeedBlitz, INO Market Report, DrStockPick, Daily Market Beat, M2 Communications, CoolPennyStocks, Money Wealth Matters, PennyOmega, BioMedWire, PoliticsAndMyPortfolio, Wealth Daily, Prism MarketView, ProActive Capital, Schaeffer's, The Online Investor, The Street, Timothy Sykes, TradersPro, Wall Street Mover and PennyTrader.com reported earlier on GeoVax Labs (GOVX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GeoVax Labs Inc. (NASDAQ: GOVX) (FRA: E8L) is a clinical stage biotechnology firm which is engaged in the development, manufacture, testing, licensing and commercialization of human vaccines that prevent and fight ailments caused by HIV-1 and other infectious agents.

The firm operates as part of the biotechnology research services industry and has its headquarters in Smyrna, Georgia. The company was founded in 1988 by Donald G. Hildebrand and Harriet Latham Robinson.

This firm is party to partnership and collaboration agreements with Leidos Inc., the University of California, the Geneva Foundation, Viamune Inc., American Gene Technologies International Inc., the Burnet Institute, the Scripps Research Institute, the University of Maryland Institute of Human Virology, University of Texas Medical Branch, Georgia State University Research Foundation, University of Pittsburgh, Emory University, U.S. Naval Research Laboratory, U.S. Army Research Institute of Infectious Disease, U.S. Department of Defense, the CDC, the HIV Vaccines Trial Network and the National Institute of Allergy and Infectious Diseases of the NIH.

The company is currently developing preventive vaccines against malaria, Zika virus, HIV and the coronavirus as well as hemorrhagic fever viruses like Lassa, Marburg and Ebola; and therapeutic vaccines for chronic Hepatitis B infections and HIV. Additionally, the firm is developing immunotherapies for solid tumor cancers.

This biotechnology firm is at the forefront of forward-thinking vaccine science. Its clinical success has improved its financial position as well its capital structure, which allows it secure long-term funding. Many expect the company to reach numerous vaccine development milestones over the next year, which will benefit both the firm and its shareholders.

GeoVax Labs (GOVX), closed Monday's trading session at $3.14, up 61.0256%, on 33,212,902 volume. The average volume for the last 3 months is 2.192M and the stock's 52-week low/high is $1.0901/$11.18.

Workhorse Group, Inc. (WKHS)

Green Car Stocks, InvestorPlace, QualityStocks, MarketClub Analysis, Schaeffer's, Kiplinger Today, StocksEarning, StockEarnings, MarketBeat, StockMarketWatch, TradersPro, StreetInsider, Early Bird, GreenCarStocks, The Street, Trades Of The Day, TraderPower, TopPennyStockMovers, The Online Investor, Daily Trade Alert, BUYINS.NET, Wealth Insider Alert, Money Wealth Matters, Zacks, InvestorsUnderground, Jason Bond, Cabot Wealth, Marketbeat.com, PoliticsAndMyPortfolio, The Night Owl, StockOodles, Daily Market Beat, Energy and Capital, NetworkNewsWire, Profitable Trader Authority, Stock Beast, The Best Newsletters, The Wealth Report, Wealth Daily and Premium Stock Alerts reported earlier on Workhorse Group, Inc. (WKHS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Workhorse Group, Inc. is a technology company centered on providing sustainable and cost-effective electric mobility solutions to the commercial electric transportation sector. The Company designs and builds high performance battery-electric vehicles including trucks and aircraft. The design of all Workhorse vehicles is to make the movement of people and goods more efficient and less harmful to the environment. An American original equipment manufacturer (OEM), Workhorse Group is based in Loveland, Ohio.

The Company designs and produces battery-electric power trains in its 50,000 sq. ft. facility in Loveland for its new Workhorse chassis. Its approach to building its battery electric power trains uses proven, automotive-grade, mass-produced parts together with its custom designed, proprietary control software.

Workhorse Group also develops cloud-based, real-time telematics performance monitoring systems. These systems are totally integrated with its vehicles. They enable fleet operators to optimize energy and route efficiency. The Company is a top manufacturer of medium-duty electric step vans in America targeting commercial fleets. Workhorse Group is the only OEM building electrified medium-duty vehicles in America.

The Company is developing the Workhorse W-15, the U.S.’ first light-duty pickup truck with electric powertrain targeted at commercial fleets. Target customers include delivery fleets, utility companies, telecommunications companies, municipalities and more. Workhorse Group has its N-GEN Electric Delivery Van; the W-15 electric pickup truck with extended range; the E-Gen Step Van; the SureFly™ Helicopter; the HorseFly™ Autonomous Drone Delivery System; and the METRON™ Telematics and Asset Tracking Software.

The SureFly is classified as a personal helicopter/eVTOL aircraft. The Company has received FAA approval to test the copter. However, it is still trying to secure approval to sell it. Mr. Steve Burns, Workhorse Group Chief Executive Officer, said the Company is "six months into a two-year journey" to get the product approved and sold.

Workhorse Group, Inc. (WKHS), closed Monday's trading session at $1.19, up 51.1111%, on 11,721,984 volume. The average volume for the last 3 months is 3.161M and the stock's 52-week low/high is $0.5725/$8.78.

GD Culture (GDC)

QualityStocks, INO Market Report, Timothy Sykes, Prism MarketView, MarketClub Analysis, Investors Underground and bullseyeoptiontrading reported earlier on GD Culture (GDC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GD Culture Group Limited (NASDAQ: GDC) is a holding firm that operates through its primary business conduit, AI Catalysis Corp.

The firm has its headquarters in Nevada and was incorporated in 2018, on February 6th. Prior to its name change in January 2023, the firm was known as Code Chain New Continent Ltd. It operates as part of the electronic gaming and multimedia industry, under the communication services sector. The firm serves consumers around the globe.

The company’s main businesses include AI-driven digital human technology; Live-streaming e-commerce; and Live streaming interactive games. Under its AI business division, it is focused on providing technology application services of digital human creation and customization for social media influencers or SMBs (Small and Medium-sized Businesses) in the consumer industry to help the clients optimize their online marketing and advertising. Under the e-commerce business, its focus is on capturing TikTok's popular trend by offering carefully selected product choices with smooth delivery, aiming to redefine the online shopping experience. It has formulated a dual strategy employing both short video and live streaming to afford online shoppers a more convenient and interactive shopping experience. On the other hand, the interactive game division is focused on diversifying its game offerings and the anchor personalities for TikTok users.

The firm, through its AI Catalysis subsidiary, announced recently that its portfolio company, DigiTrax Entertainment Inc. had unveiled a new AI Music Training Model License offered in its patented AI platform KR38R LAB’s Artist and Label Services. This move unlocks innovative AI-driven creative possibilities and may positively influence investments into the firm.

GD Culture (GDC), closed Monday's trading session at $2.28, up 39.0244%, on 8,097,672 volume. The average volume for the last 3 months is 147,802 and the stock's 52-week low/high is $0.585175/$12.18.

Aligos Therapeutics (ALGS)

QualityStocks, MarketBeat, Prism MarketView, Premium Stock Alerts, Penny Stock and InsiderTrades reported earlier on Aligos Therapeutics (ALGS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aligos Therapeutics Inc. (NASDAQ: ALGS) (FRA: 5WK) is a clinical-stage biopharmaceutical firm that is engaged in the development of new therapeutics that address unmet medical needs for various indications.

The firm has its headquarters in San Francisco, California and was incorporated in 2018, on February 5th by Lawrence M. Blatt and Lucinda Quan. It operates as part of the medical and diagnostic laboratories industry, under the health care sector. The firm has two companies in its corporate family and serves consumers around the globe, with a focus on the United States.

The company is party to a research partnership with VipergenApS, which entails the development of its DEL-based (DNA Encoded Library) drug discovery system for liver illnesses and viral infections. The company is also party to a license and collaboration agreement with Luxna Biotech Co. Ltd, for the development and commercialization of products which contain oligonucleotides that target SARS-CoV-2. In addition to this, it is party to a research, licensing and commercialization agreement with Katholieke Universiteit Leuven, which entails the development of coronavirus protease inhibitors.

The enterprise’s product pipeline is comprised of a small molecule agonist dubbed ALG-055009, which has been developed to treat non-alcoholic steatohepatitis; an antisense oligonucleotide dubbed ALG-020572, indicated for decreasing HBsAg levels; and a capsid assembly modulator known as ALG-000184, which is undergoing phase 1 clinical trials evaluating its effectiveness in treating chronic hepatitis B. It also develops a synthetic oligonucleotide dubbed ALG-010133 for the treatment of chronic hepatitis B. In addition to this, the enterprise develops ALG-125819, ALG-125097 and ALG-125755.

The company recently expanded its collaboration agreement with Merck, which will facilitate the development of targeted and effective therapies for non-alcoholic steatohepatitis. This move not only strengthens the relationship between the two companies but also brings them closer to success, which will positively influence the growth of both firms.

Aligos Therapeutics (ALGS), closed Monday's trading session at $13.99, up 37.2915%, on 3,161,531 volume. The average volume for the last 3 months is 189,160 and the stock's 52-week low/high is $6.76/$30.00.

Semler Scientific, Inc. (SMLR)

QualityStocks, Wall Street Resources, MarketBeat, Top Pros' Top Picks, StreetInsider, StockEarnings, Money Wealth Matters, Money Morning, MarketClub Analysis, Marketbeat.com, InsiderTrades, Daily Trade Alert and Barchart reported earlier on Semler Scientific, Inc. (SMLR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Semler Scientific, Inc. is a medical risk-assessment Company headquartered in San Jose, California. Its mission is to develop, manufacture, and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Semler Scientific provides technology and software solutions to improve the clinical effectiveness of healthcare insurers and physician groups. Semler Scientific lists on the OTC Markets Group’s OTCQB.

In essence, Semler Scientific provides diagnostic and testing services to the U.S.’s leading health plans and providers. The Company’s goal is to develop, manufacture, and market innovative proprietary products and services, which assist its customers in evaluating and treating chronic diseases.

Semler Scientific manufactures the QuantaFlo system for Vascular Disease testing. The QuantaFlo system is very suitable for use in primary care offices, specialty practices, health fairs, or during home assessments. 

The QuantaFlo PAD test delivers quick, accurate results in approximately five minutes at the point of care. In March 2015,  The Company received Food and Drug Administration (FDA)  510 (k) clearance for the next generation version of QuantaFlo, which commercially launched in August 2015. The QuantaFlo software can be installed on any Windows based PC, laptop or tablet.

Semler Scientific's first patented and FDA cleared product, introduced commercially in 2011, measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease.

Semler Scientific, Inc. (SMLR), closed Monday's trading session at $52.14, up 30.8735%, on 1,403,002 volume. The average volume for the last 3 months is 242,342 and the stock's 52-week low/high is $20.88/$54.44.

James River (JRVR)

MarketBeat, StreetInsider, Zacks, The Wealth Report, Schaeffer's, Daily Trade Alert, InvestorPlace, MarketClub Analysis, Trading Concepts, Marketbeat.com, Top Pros' Top Picks, Barchart, TradersPro, InvestorsObserver Team, Trades Of The Day and Greenbackers reported earlier on James River (JRVR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

James River Group Holdings Limited (NASDAQ: JRVR) is an insurance holding firm engaged in the provision of specialty insurance services.

The firm has its headquarters in Pembroke, Bermuda and was incorporated in 2007, on May 30th. It operates as part of the insurance-specialty industry, under the financial services sector. The firm serves consumers in the United States.

The company’s objective is to generate compelling returns on tangible equity while limiting underwriting and investment volatility. It seeks to accomplish this by earning profits from insurance underwriting and generating meaningful risk-adjusted investment returns, while managing its capital.

James River Group operates through the Specialty Admitted Insurance and Excess and Surplus Lines segments. The Specialty Admitted Insurance segment focuses on workers’ compensation insurance coverage as well as specialty admitted fronting and program business. On the other hand, the Excess and Surplus Lines segment offers excess and surplus commercial lines liability and property insurance in every state in the United States, the District of Columbia, Puerto Rico and the United States Virgin Islands through James River Insurance and its wholly-owned subsidiary, James River Casualty. Through Falls Lake National and its subsidiaries, the enterprise has admitted licenses and the authority to write excess and surplus lines insurance in 50 states and the District of Columbia and distributes through a variety of sources, including program administrators and MGAs.

The firm, which is party to a combined loss portfolio transfer and adverse development cover reinsurance agreement with State National Insurance Company Inc., remains committed to generating additional value for its shareholders.

James River (JRVR), closed Monday's trading session at $6.62, up 1.0687%, on 192,958 volume. The average volume for the last 3 months is 20.149M and the stock's 52-week low/high is $6.05/$11.49.

Alibaba Group Holding Ltd. (BABA)

InvestorPlace, The Street, Kiplinger Today, Schaeffer's, MarketClub Analysis, Zacks, Money Morning, StreetInsider, Trades Of The Day, Daily Trade Alert, Marketbeat, Market Intelligence Center Alert, StocksEarning, Investopedia, The Online Investor, Wealth Insider Alert, StreetAuthority Daily, Early Bird, ProfitableTrading, QualityStocks, CustomerService, Marketbeat.com, Louis Navellier, TopStockAnalysts, Uncommon Wisdom, GorillaTrades, StockEarnings, Top Pros' Top Picks, TipRanks, Cabot Wealth, CNBC Breaking News, AllPennyStocks, Profit Confidential, The Wealth Report, Investors Alley, Options Elite, Total Wealth, INO.com Market Report, Money and Markets, Daily Profit, Street Insider, Barchart, The Street Report, Wyatt Investment Research, SmallCapVoice, StrategicTechInvestor, Investing Daily, Market Intelligence Center, Insider Wealth Alert, Power Profit Trades, Daily Wealth, Average Joe Options, Investing Signal, FreeRealTime, Trade of the Week, INO Market Report, Wealth Daily, MarketTamer, WStreet Market Commentary, Earnings360, The Best Newsletters, MarketWatch, Trader Prep, Wall Street Daily, Trading Concepts, BUYINS.NET, Short Term Wealth, Rick Saddler, Inside Investing Daily, TheOptionSpecialist, Investors Underground, Dynamic Wealth Report, InvestmentHouse, ChineseWire, StockReport, Visual Capitalist, 24/7 Trader, Investment U, OptionAlarm News, SureMoney, Investing Futures, Investing Lab, Energy and Capital, Wealthpire Inc., InvestorsHQ, Agora Financial, Daily Dividends, MarketArmor.com, The Weekly Options Trader, Eagle Financial Publications, wyatt research newsletter, Dividend Opportunities, Direction Alerts, Beat The Street, Energy & Resources Digest, Atomic Pennies, Financial Freedom Post, BillionDollarClub, DividendStocks, Chaikin PowerFeed, 24-7 Stock Alert, Goldman Small Cap Research, Equities.com, Terry's Tips, Liberty Through Wealth, Rockwell Trading, Shah's Insights & Indictments, SmallCapNetwork, Stock Gumshoe, Outsider Club, Summa Money, Navellier Growth, The Growth Stock Wire, The Night Owl, The Stock Dork, Wallstreet Journal, The Trading Report, TheoTrade, StockMarketWatch, InvestorsObserver Team, Hit and Run Candle Sticks, Inside Trading, InsiderTrades, Investiv, Investment House, Profits Run, InvestorGuide, Greenbackers, Jim Cramer, Kiplinger’s Weekly Update, Market Authority, Weekly Wizards, MarketDeal, wealthmintrplus and Investor Guide reported earlier on Alibaba Group Holding Ltd. (BABA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alibaba Group Holding Ltd.’s (NYSE: BABA) research firm DAMO Academy has launched an artificial intelligence (AI) weather forecasting model with enhanced forecasting accuracy. Dubbed ‘Baguan,’ the AI-powered weather forecasting model can predict weather conditions for up to 10 days with hourly updates and much higher accuracy compared to current weather forecasting tools.

Industries will need tools such as Baguan to limit their impact on the environment and adapt to climate change-induced volatility. DAMO Academy developed the AI weather forecasting tool to increase meteorological precision amidst a surge in extreme climate events.

Several regions across the world are contending with extreme fires, droughts, landslides, tropical storms and floods that have taken many lives and caused significant economic damage. With the effects of climate change becoming more apparent each day, increased accuracy in meteorology will allow experts to predict such events with greater accuracy and, hopefully, help them save more lives.

According to the World Meteorological Organization (WMO), the effects of severe weather and climate change risk the planet’s and humanity’s wellbeing. Leveraging artificial intelligence and machine learning could help alleviate these risks by increasing the accuracy and speed of weather modeling tools. AI and machine learning can allow lower-income nations to access such tools by making them less costly.

Alibaba DAMO Academy Director of Decision Intelligence Lab Wotao Yin says Baguan DAMO can help improve climate science while benefiting eco-friendly practices in a wide array of industries. DAMO Academy developed the AI weather forecasting model using a new autoregressive pre-training methodology SiamMAE (Siamese Masked Auto encoders) architecture.

The model can process and understand atmospheric data at a very high level, allowing for significantly more precise weather forecast predictions. These predictions can help the energy industry optimize its production, especially renewables like wind and solar, and help the sector stabilize and optimize its power management.

Baguan demonstrated its enhanced precision during the recent Shandong Province, China temperature drop where it accurately predicted that there would be a 20% fall in electricity demand. The accurate prediction helped to reduce costs, improved the efficiency of energy distribution post-temperature drop, and boosted grid operation. Used on a much larger scale, Baguan and other similar tools can have major benefits for the grid and energy customers.

Yin noted that DAMO Academy would continue working to improve the tool’s ability to predict critical weather indicators like precipitation and cloud cover, develop novel tools to analyze different climate scenarios and support additional applications such as sports events preparations, agricultural production, and civil aviation meteorological warnings.

Alibaba Group Holding Ltd. (BABA), closed Monday's trading session at $95.42, up 1.3059%, on 12,556,730 volume. The average volume for the last 3 months is 4.227M and the stock's 52-week low/high is $66.63/$117.82.

Match Group (MTCH)

Schaeffer's, InvestorPlace, Marketbeat, MarketClub Analysis, StocksEarning, The Street, Kiplinger Today, Daily Trade Alert, StockEarnings, StreetInsider, Trades Of The Day, Trading Tips, QualityStocks, Money Wealth Matters, Daily Wealth, Stockpalooza, Zacks, Investopedia, Market Intelligence Center Alert, Stock Stars, Wealth Insider Alert, The Online Investor, Trading Concepts, StockHotTips, Top Pros' Top Picks, Stock Rich, Marketbeat.com, HotOTC, Louis Navellier, StockMarketWatch, StockEgg, CNBC Breaking News, OTCReporter, Penny Invest, StreetAuthority Daily, CoolPennyStocks, OTC Advisors, SmallCapVoice, Barchart, FreeRealTime, TopStockAnalysts, BUYINS.NET, InvestmentHouse, Investment U, InsiderTrades, GorillaTrades, Energy and Capital, Early Bird, Cabot Wealth, Epic Stock Picks, Wealth Daily, StockPickss, Standout Stocks, The Stock Dork, Titan Stocks, PennyOmega, Topgun stockpicks, Monster Stox, TipRanks, Chaikin PowerFeed, Stock Market Watch, BloomMoney, Wall Street Daily, Daily Profit, XplosiveStocks, The Motley Fool, DividendStocks, Uncommon Wisdom, The Trading Report, Stock Traders Chat, OTCPicks, GusherStocks, Profit Confidential, Investiv, Investment House, SpeculatingStocks, Smart Investing Today, wyatt research newsletter, InvestorsObserver Team, WStreet Market Commentary, PennyStockRumors.net, Wise Alerts and Stock Marketing Inc. reported earlier on Match Group (MTCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Match Group (NASDAQ: MTCH) recently reported its third-quarter earnings, exceeding market expectations. The company, known for its popular dating platforms like Tinder and Hinge, saw a year-over-year increase in revenues. This growth was largely driven by Hinge’s strong performance in direct revenues and downloads. However, the overall growth in total payers was slower than anticipated.

Match Group’s financial metrics provide a deeper understanding of its market position. The company’s price-to-earnings (“P/E”) ratio is approximately 9.94, which indicates how the market values its earnings. A lower P/E ratio can suggest that the stock is undervalued compared to its earnings. Additionally, the price-to-sales ratio of about 2.36 reflects the company’s market value relative to its revenue, offering insight into how much investors are willing to pay per dollar of sales.

The enterprise value to sales ratio, standing at around 3.22, includes the company’s debt and cash in its valuation. This ratio helps investors understand the company’s total value in relation to its sales. Furthermore, the enterprise value to operating cash flow ratio is approximately 11.77, indicating how the company’s cash flow is valued in relation to its enterprise value. This ratio is crucial for assessing the company’s ability to generate cash from its operations.

Match Group’s earnings yield is about 10.06%, providing a perspective on the return on investment for shareholders. This yield is a useful metric for comparing the company’s profitability to other investment opportunities. The company also has a unique capital structure, with a negative debt-to-equity ratio of approximately -43.81. This suggests that Match Group has more liabilities than equity, which can be a point of concern for investors.

Lastly, the current ratio of approximately 2.49 indicates Match Group’s ability to cover its short-term liabilities with its short-term assets. A current ratio above 1 suggests that the company is in a good position to meet its short-term obligations, which is a positive sign for its financial health.

To view the company’s latest earnings release, visit https://ibn.fm/qJkRs

About Match Group Inc.

Match Group, through its portfolio companies, is a leading provider of digital technologies designed to help people make meaningful connections. Its global portfolio of brands includes Tinder(R), Hinge(R), Match(R), Meetic(R), OkCupid(R), Pairs(TM), PlentyOfFish(R), Azar(R), BLK(R), and more, each built to increase its users’ likelihood of connecting with others. Through the company’s trusted brands, it provides tailored services to meet the varying preferences of its users. Match Group’s services are available in over 40 languages to users all over the world.

Match Group (MTCH), closed Monday's trading session at $31.94, up 4.5157%, on 6,317,912 volume. The average volume for the last 3 months is 697,825 and the stock's 52-week low/high is $27.655/$42.425.

Zoomcar Holdings Inc. (ZCAR)

Premium Stock Alerts, FreeRealTime, 360 Wall Street and QualityStocks reported earlier on Zoomcar Holdings Inc. (ZCAR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aegis Capital Corp. has been in the wealth management and investment banking business since 1984 and is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis has announced that it acted as exclusive placement agent on a $9.15 million private placement for Zoomcar Holdings (NASDAQ: ZCAR). According to ZCAR, the company used the net proceeds from the private placement to repay approximately $3.8 million of outstanding indebtedness to certain institutional investors and intends to use the remainder for general corporate purposes and working capital.

To view the full press release, visit https://ibn.fm/8TpEs

About Zoomcar Holdings Inc.

Founded in 2013 and headquartered in Bengaluru, India, Zoomcar is a leading marketplace for car sharing focused in India. The Zoomcar community connects hosts with guests, who choose from a selection of cars for use at affordable prices, promoting sustainable, smart transportation solutions in India.

Zoomcar Holdings Inc. (ZCAR), closed Monday's trading session at $6.8, off by 3.5461%, on 309,753 volume. The average volume for the last 3 months is 752,743 and the stock's 52-week low/high is $3.9301/$1289.00.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, PsychedelicNewsWire, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Prism MarketView, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Voters in the state of Massachusetts have rejected a ballot measure that would’ve removed penalties for the sharing, possession, and non-commercial production of a range of naturally occurring psychedelics.

Results from the election night show that 57% of voters voted No to Question 4, which would’ve permitted individuals aged 21 and above to use psilocyn, psilocybin, mescaline, ibogaine, and DMT. Eligible persons would’ve also been able to cultivate a personal amount of these psychedelics and been able to help others in those activities.

The limits for possession stipulated in the measure were 1g for psilocybin, psilocyn or DMT, 30g for ibogaine, and 18g for mescaline. Possessing higher amounts was classified as a civil offense punishable by a $100 fine. Those found in possession of more than twice the stipulated amount would’ve been charged with a criminal offense.

Under the state’s current law, possessing psychedelics is punishable by up to 12 months in jail for first-time offenders and up to 2 years for the second strike.

The measure would’ve also allowed the establishment of state-licensed psychedelic treatment centers. The on-site consumption of the psychedelics at treatment centers would’ve been regulated by a commission focused on Natural Psychedelic Substances.

Additionally, the measure would’ve imposed a 15% tax on psychedelic purchases and permitted local governments to levy additional taxes not exceeding 2%. Furthermore, local governments would’ve been allowed to regulate the therapy centers without banning them.

Massachusetts for Mental Health Options led the Question 4 campaign and primarily emphasized the psychotherapeutic potential of psychedelic substances. The group also discussed how the measure would permit regulated access to psychedelic drugs with the potential to manage depression, anxiety, and treatment-resistant post-traumatic stress disorder.

They also called attention to the fact that the drugs would only be available in approved settings and be administered under the supervision of licensed and trained facilitators.

The measure was opposed by various organizations, led by Coalition for Safe Communities, who depicted it as a rash experiment. In a statement, the organization explained that while it wasn’t advocating against the medicinal properties of psychedelics, the measure didn’t address any concerns raised by mental health professionals and public safety advocates.

Question 4 is similar to a resolution voters in the state of Colorado approved two years ago, which covered the same drugs. Both resolutions also went further than a 2020 measure introduced in Oregon that permitted the establishment of state-licensed psilocybin service centers only and didn’t allow personal use.

The rejection of the decriminalization measure in Massachusetts shows how unreliable it may be to use the ballot to enact major drug policy reforms targeting psychedelics. A more dependable route is the one that entities like Compass Pathways PLC (NASDAQ: CMPS) have opted for, which entails developing treatments that can be approved by regulators like the FDA and become available within the mainstream medical system.

Compass Pathways PLC (CMPS), closed Monday's trading session at $5.31, off by 2.5688%, on 959,042 volume. The average volume for the last 3 months is 477,492 and the stock's 52-week low/high is $4.05/$12.75.

Verano Holdings Corp. (VRNOF)

QualityStocks, CannabisNewsWire, MarketBeat, InvestorPlace, The Street, Earnings360, Early Bird and Cabot Wealth reported earlier on Verano Holdings Corp. (VRNOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hemp was federally legalized with the passage of the 2018 Farm Bill, making its cultivation and sale legal. Both hemp and marijuana are varieties of the cannabis plant, with anything with a THC content of 0.3% or less being defined as hemp.

Anything with a THC content above 0.3% is considered marijuana, which is federally illegal due to its classification under Schedule I of the Controlled Substances Act. Other drugs under this classification include heroin, LSD, and peyote.

About a month ago, the Tennessee Department of Agriculture released new regulations based on a legislation that sought to regulate the state’s hemp industry. The finalized regulations were announced in late September after temporary emergency regulations were introduced earlier in the year.

A representative from the state’s agriculture department stated that the regulations were promulgated in agreement with legislative directives and the statutory authority to administer a program for cannabinoid products derived from hemp. They noted that the regulations were consistent with its statutory authority to regulate hemp and THC products, not ban them.

The finalized regulations will go into effect on December 26th, 2024, and enact several requirements, ranging from taxation and labelling to testing and licensing. For instance, the new regulations impose a ban on an entire category of hemp products, particularly THCA products that can be burnt.

They also measure THC amounts after the decarboxylation process, which includes burning or heating. This is worrying hemp producers, as the amount of THC can increase after this process, which means that THCA products can surpass the legal threshold, and retailers can’t sell the products anymore.

Critics of the new regulations also worry that some hemp retailers may have to move their businesses to other states or even close shop because a considerable portion of their products can’t be sold legally. They add that millions in tax revenue may be lost when these products can no longer be sold.

Alex Little, attorney to the Hemp Law Group, explains that inhalables are impacted by this while edibles aren’t. Despite this, he continues, many individuals in the industry are generally supportive of the statutory rules that establish packaging requirements, age limits, and impurity tests for products.

In response to the regulations, the attorney has filed petitions with the agriculture department on behalf of a pair of East Tennessee hemp firms and the Tennessee Growers Coalition. Little notes that if the department doesn’t allow the petitions, he and his clients will forward the matter to chancery court.

Many jurisdictions, such as those where Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) operates, are grappling with how best to regulate the hemp products that have proliferated and many are intoxicants, which positions them as alternatives to marijuana products and yet the latter are heavily regulated.

Verano Holdings Corp. (VRNOF), closed Monday's trading session at $1.53, off by 20.9302%, on 2,124,265 volume. The average volume for the last 3 months is 304,400 and the stock's 52-week low/high is $1.42/$7.08.

TerrAscend Corp. (TSNDF)

QualityStocks, CannabisNewsWire, InvestorPlace and Cabot Wealth reported earlier on TerrAscend Corp. (TSNDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Six percent of women reported using cannabis while pregnant, according to a recent study, despite studies indicating that using cannabis during pregnancy can be harmful to both the fetus and the expectant mother.

Researchers from the University of Georgia found this concerning as it suggests more than one in every 20 pregnancies may be affected by marijuana use. Most women surveyed seemed to perceive cannabis as a harmless remedy and have turned to it to manage symptoms like morning sickness.

According to the study’s lead author, Mohammad Haider, using cannabis for nausea during pregnancy is risky. He emphasized that this isn’t a safe solution for expectant mothers. The study analyzed data from federal surveys of 4,338 expectant women. Of those surveyed, around 5.7% reported using marijuana in the previous month.

The findings indicated that marijuana use among pregnant women is highest during the first trimester and declines as pregnancy advances, likely suggesting its use as a response to early pregnancy nausea. Interestingly, a large portion of these women—around 71%—believed that their marijuana use posed little or no risk to themselves or their babies. However, previous research has linked cannabis use in pregnancy to premature delivery, low weight at birth, and developmental issues in children.

The study also pointed out that two-thirds of the pregnant women who reported using marijuana lived in one of the states where medical cannabis is legal. Haider noted that the accessibility of marijuana in these states could unintentionally contribute to its use during pregnancy.

He explained that when medical cannabis is legally available in pharmacies, it becomes more accessible, which may lead pregnant women to use it without fully understanding the potential dangers. He suggested that states with legal access to medical cannabis should implement policies that educate pregnant women on the possible negative effects of cannabis use during pregnancy.

Haider and his research team noted that safer, prescribed medications are available to alleviate morning sickness. They recommended that women consult their healthcare providers to explore alternatives before considering cannabis. Additionally, Haider highlighted that women with a history of mental health issues or substance use may be more likely to turn to cannabis while pregnant, putting them and their babies at further risk.

“This is a vulnerable group,” Haider stated, “and research shows that cannabis use during pregnancy can be harmful to both child and mother.” He added that more state-level policies are needed to guide and inform women about the potential risks associated with marijuana use during pregnancy.

As pressure mounts to make even more federal regulatory changes to marijuana policies, industry actors like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) will find it easier to conduct studies geared at giving patients more targeted information about how best to benefit from their products while keeping risks minimal.

TerrAscend Corp. (TSNDF), closed Monday's trading session at $0.67, off by 27.1739%, on 865,629 volume. The average volume for the last 3 months is 4.688M and the stock's 52-week low/high is $0.67/$2.45.

The QualityStocks Company Corner

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

The U.S. Department of Defense's Chief Digital and Artificial Intelligence Office's ("CDAO") Tradewinds Solutions Marketplace is a comprehensive suite of tools and services for accelerating the procurement of emerging technologies by the Department of Defense ("DoD").

D-Wave's presence on the marketplace will enable DoD customers to more easily adopt the company's annealing quantum computing technologies and solutions.

D-Wave Quantum (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has been deemed "Awardable" through the Department of Defense ("DoD") Chief Digital and Artificial Intelligence Office's ("CDAO") Tradewinds Solutions Marketplace, a premier suite of tools and services for accelerating the procurement and adoption of emerging technologies (https://ibn.fm/POyFC).

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Monday's trading session at $1.63, up 1.875%, on 13,489,534 volume. The average volume for the last 3 months is 117,176 and the stock's 52-week low/high is $0.6813/$2.44.

Recent News

HealthLynked Corp. (OTCQB: HLYK)

The QualityStocks Daily Newsletter would like to spotlightFathom HealthLynked Corp. (OTCQB: HLYK) .

HealthLynked (OTCQB: HLYK) has announced a significant update to its Oohvie app, integrating telemedicine services and online scheduling to offer a more comprehensive healthcare experience for women. The update includes a redesigned home screen, enhanced user interface, and expanded functionalities, enabling users to manage their health more effectively through a single platform. CEO Dr. Michael Dent stated that the alignment of Oohvie's features with the HealthLynked network simplifies personalized, connected care by providing access to telemedicine, appointment scheduling, and secure health data management in one place.

To view the full press release, visit https://ibn.fm/C4jIm

HealthLynked Corp. (OTCQB: HLYK) is at the forefront of a transformative movement in healthcare, utilizing its extensive collection of health data to improve care for all. With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries.

HealthLynked Corp. App

In addition to these capabilities, HealthLynked provides a user-friendly platform for booking healthcare appointments, similar to how OpenTable operates for restaurant reservations. This feature allows patients to conveniently book appointments with healthcare providers across the country, including options for telemedicine consultations, enhancing accessibility and efficiency in healthcare service delivery.

Strategically headquartered in Naples, Florida, HealthLynked operates through three primary divisions: Health Services, Digital Healthcare, and Medical Distribution. Each division supports the company’s mission to revolutionize patient care and health management. Positioned as a potential leader in healthcare AI, HealthLynked is dedicated to shaping the future of the industry over the next 20 years, driving significant advancements in healthcare accessibility and effectiveness through innovation and technology.

HealthLynked Corp. Reach

Strategic Initiatives and Operational Highlights

The company’s commitment to enhancing global health is evident in its dual goals: transforming healthcare through advanced technology and creating a patient-centric network that accelerates medical discoveries and the development of disease cures.

HealthLynked’s intellectual property portfolio is robust and strategically developed to enhance healthcare delivery and management. In March 2023, HealthLynked was granted a patent for a groundbreaking healthcare-specific wireless access point, known as the “Patient Access Hub.” This technology significantly improves the efficiency of healthcare practices by enabling real-time monitoring of patient flow within facilities. It intelligently determines patients waiting in exam rooms and calculates wait times, alongside other critical practice metrics. This system not only enhances patient experience by reducing unnecessary wait times but also optimizes resource allocation within healthcare settings.

Additionally, in October 2023, HealthLynked filed a patent application for its advanced AI program, ARI (Augmented Real-time Interface). ARI acts as a virtual doctor for patients, capable of performing medical intake, booking appointments, and providing personalized medical recommendations based on a patient’s medical history. By integrating these tasks, ARI streamlines the healthcare process, reducing the administrative burden on healthcare providers and ensuring that patients receive timely and tailored healthcare advice. This AI-driven interface enhances the accessibility and personalization of healthcare, embodying HealthLynked’s commitment to leveraging technology for better health outcomes. The company recently launched HealthLynked 3.2.0, an advanced version of its application, incorporating telemedicine, AI-driven personal healthcare guidance, and remote patient monitoring – setting a new standard in healthcare technology.

Market Position and Future Outlook

According to Facts and Figures Research, a research and consulting firm, the global market for patient-centric healthcare applications is projected to reach $41.6 billion by 2030, growing at a CAGR of 18.77% from 2022. HealthLynked’s offerings align perfectly with this expansive market opportunity, especially with increasing demands for digital health solutions and data management in healthcare.

HealthLynked’s strategic direction, spearheaded by its seasoned management team, is designed to leverage these market dynamics, enhancing patient engagement and healthcare efficiency on a global scale.

Management Team

Michael T. Dent, M.D., Founder, CEO, and Chairman, brings extensive experience from his foundational role at NeoGenomics and leadership in various healthcare and technology sector companies.

David Rosal, CFO, with previous senior roles at Teradata and McDonald’s Corporation, brings a wealth of expertise in financial and business integration strategies essential for growth and operational efficiency.

Chris Hall, CTO, with a strong background in global technology development from his time at Siemens and several patents to his name, is instrumental in driving the innovation and technological advancement at HealthLynked.

Bill Crupi, Operations Manager, has a proven track record in streamlining operations and enhancing productivity across multiple sectors within the healthcare industry. His expertise is crucial in maintaining the operational excellence that HealthLynked is known for.

Michael Paisan, Director of Investor Relations, leverages his extensive experience in finance and communications to enhance HealthLynked’s relationships with investors and stakeholders, ensuring transparent and effective communication of the company’s value and growth strategy.

Gagan Babber, Manager of Software Development, oversees the HealthLynked development teams based in the U.S. and India. With a robust background in engineering and software development, he plays a critical role in guiding the technological direction of HealthLynked’s products. His expertise in developing scalable, innovative software solutions is essential for driving the company’s technical initiatives forward and ensuring that HealthLynked stays at the forefront of digital healthcare technology.

HealthLynked Corp. (OTCQB: HLYK), closed Monday's trading session at $0.029, up 0.9573542%, on 503,753 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.44/$.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Web3 technology is quickly redefining the gaming world by offering benefits beyond traditional game rewards. With blockchain, tokenization and smart contracts, Web3 gaming has introduced new ways to engage players, reward skills, and provide real ownership of digital achievements. This shift is creating a strong foundation for the future of gaming. Competitive gaming has long been a core part of gaming culture, giving players a sense of accomplishment and satisfaction. Recent studies reveal that regular competitive gaming fulfills key psychological needs, such as autonomy, competence, and social connection while reducing psychological distress. Web3 is set to build on this foundation by incorporating elements that enhance player engagement and personal reward, pushing the boundaries of what gaming can offer. It is pretty clear that Web3 technology is setting a new standard in gaming by offering players tangible rewards and true ownership of their in-game assets. The shift not only improves the gaming experience but also promises a sustainable future where both players and developers thrive in a more interactive and valuable digital ecosystem. The adoption of Web3 isn't only happening in the gaming sphere alone; these technologies are spreading their wings and finding a home in many industries, such as within the securities trading space where companies like Horizon Fintex are leveraging them to offer superior services and products to their target markets.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).

Annovis Bio (NYSE: ANVS) provided a third-quarter update, announcing significant progress in developing its lead drug candidate, buntanetap, for Alzheimer's disease ("AD") and Parkinson's disease ("PD"). Following a successful Phase 2 meeting with the FDA, Annovis received clearance to initiate two Phase 3 studies for AD: a six-month trial to evaluate symptomatic relief and an 18-month trial to assess disease-modifying potential, with the first study slated to start in Q1 2025. Financially, the company raised $12.7 million through its equity line of credit and $7.1 million from warrant exercises, securing its runway to enter Phase 3 trials. Annovis also strengthened its intellectual property with new patents for buntanetap combination therapies and expanded its team with the appointment of Senior Clinical Scientist Dr. Matthew Peterson to support trial quality and completion.

To view the full press release, visit https://ibn.fm/MOzXr

Annovis Bio Inc. Overview

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as AD and PD. Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach addresses both the cognitive decline in AD and the motor dysfunction in PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly known as Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a 3.3 point improvement compared to 0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating buntanetap’s mechanism of action.

Similarly, in the recently completed Phase III study of buntanetap in patients with early PD, buntanetap significantly improved disease-related daily non-motor and motor functions in Parkinson’s patients who had a diagnosis over 3 years as well as improved cognition in all PD patients. It further underscores buntanetap’s potential as a transformative therapy.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050​ (Alzheimer’s Association)​​ (Republican Policy Committee)​. Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease​ (SingleCare)​.

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050​​. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Recent Phase III data in Parkinson’s Disease patients demonstrates significant improvements in motor and cognitive functions.
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

  • Maria L. Maccecchini, Ph.D. – Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.
  • Cheng Fang, Ph.D. – Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.
  • Michael Christie, Ph.D. – VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.
  • Melissa Gaines – Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.
Recent Achievements

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Investment Considerations
  • Unique Market Position: Annovis Bio is uniquely positioned as the only company developing a drug for both AD and PD that inhibits multiple neurotoxic proteins simultaneously.
  • Strong Clinical Results: Buntanetap’s Phase II/III data shows significant cognitive improvement in early AD patients, and the recent Phase III data in PD patients further validates its broad therapeutic potential.
  • Strategic Growth Plans: With recent successful trial results, Annovis Bio is poised for future growth, supported by strong patent protections and upcoming clinical trials.
  • Significant Market Need: As the prevalence of neurodegenerative diseases continues to rise, the demand for effective treatments like buntanetap remains critical.

Annovis Bio continues to advance its mission of developing transformative therapies for neurodegenerative disorders. The company recently announced statistically significant data from its Phase II/III Alzheimer’s study, demonstrating the potential of its lead drug candidate, buntanetap, to improve cognition in patients with early Alzheimer’s Disease (AD). Additionally, the company has released promising data from its Phase III study of buntanetap in patients with early Parkinson’s Disease (PD), which highlights significant advancements in both cognitive and motor functions. These milestones underscore the expanding therapeutic reach of buntanetap.

Annovis Bio Inc. (NYSE: ANVS), closed Monday's trading session at $7.65, off by 6.25%, on 605,739 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.53/$22.49.

Recent News

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBR Safe (NASDAQ: SOBR) ("SOBRsafe") develops and sells a passive, preventative alcohol screening device called the SOBRcheck(TM) and a continuous alcohol monitoring wristband called SOBRsure(TM). "SOBRcheck is fitted with two sensors, one of which scans biometrics data from a user's fingerprint, with the other detecting any alcohol excreted from the pores in the tip of the finger. The device is powered by the SOBRsafe software platform, which relays results in real time, improving employee throughput at point-of-care facilities. The SOBRsure(TM) device is equally configured to provide app-based reporting via the SOBRsafe platform, support GPS tracking and send removal alerts," a recent article reads.

"In 2024, and consistent with our strategy, we have now established our technology, with our first revenue-generating customers in behavioral health growing to 35 accounts in the first and second quarters of this year. In addition, we entered the equivalent verticals in Australia and New Zealand and are gaining traction through a channel partner that we are very excited about. Finally, further international expansion is underway," CEO Dave Gandini is quoted as saying.

To view the full article, visit https://ibn.fm/iCaKw

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Monday's trading session at $4.87, off by 1.6162%, on 64,394 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.70/$87.945.

Recent News

Torr Metals Inc. (TSX.V: TMET)

The QualityStocks Daily Newsletter would like to spotlightFathom Torr Metals Inc. (TSX.V: TMET) .

Torr Metals Inc. (TSX.V: TMET), a Vancouver-based mineral exploration company, is pursuing cost-effective strategies with higher potential for returns, focusing on district-scale areas with low exploration maturity and strong prospects for new copper and gold discoveries. "With 100% ownership of nearly 1,200 km², Torr's projects enjoy direct highway access, proximity to power grids, and established mining infrastructure, allowing operations near local towns and cities. In short, Torr is unlocking underexplored regions with major discovery potential, where operation costs are low and mining giants are already invested with dwindling mines that will require feed," reads a recent article.

"My background is in structural geology," TMET President and CEO Malcolm Dorsey explained in a MiningNewsWire podcast. "I like to start with the bigger picture, then scale down to pinpoint districts where I believe major new discoveries can be made. I'm not chasing after old frontiers with familiar outcomes – finding something new requires piecing together the puzzle to uncover that ‘needle in a haystack,' which is precisely what structural geology enables. With Torr we have adjacent infrastructure and newly defined, large-scale undrilled anomalies, which sets the stage for potential breakthrough discoveries that create substantial upside for investors as we unlock fresh value in underexplored regions."

To view the full article, visit https://ibn.fm/k1nY

Torr Metals Inc. (TSX.V: TMET) operates as a mineral exploration company focusing on the identification, acquisition, and advancement of mineral properties. With full 100% ownership of over 1,000 square kilometers of gold and copper projects strategically positioned in premier low-cost mining jurisdictions, Torr is poised for substantial returns across various promising regions.

The company’s extensive portfolio encompasses multiple district-scale projects, including the Filion Gold Project in northern Ontario, the Kolos Copper-Gold Project in south-central British Columbia, and the Latham Copper-Gold Project in northern British Columbia. These projects are all located in prolific mining regions with paved highway access, robust support infrastructure, and favorable geological conditions offering significant potential for new discoveries.

Headquartered in Vancouver, British Columbia, Torr Metals is ideally situated to leverage its expertise and resources for continued exploration and growth.

Projects

Kolos Copper-Gold Project

Situated within British Columbia’s prime copper-producing belt, the 140-square-kilometer Kolos Copper-Gold Project exhibits Nicola Belt geology similar to notable porphyry mines, including Copper Mountain and Highland Valley, respectively situated 106 kilometers to the south and 30 kilometers to the northwest.

With field operations based in the nearby city of Merritt and year-round access provided via Highway 5, the Kolos Project showcases substantial discovery upside potential with five defined large-scale copper-gold-molybdenum anomalies untested by drilling.

Torr Metals’ primary focus lies in unlocking the potential for major new discoveries at the Kolos Copper-Gold Project, with recent surface geochemical results marking a significant milestone positioning the company as a new key player in the region.

Filion Gold Project

The 261-square-kilometer Filion Project is situated within a largely unexplored greenstone belt where gold was initially discovered in the 1930s. With a comparable geological setting to regional orogenic gold deposits and multiple newly identified and undrilled gold trends in surficial geochemistry, the Filion Project holds significant district-scale exploration promise.

The Filion Project benefits from unparalleled infrastructure access, with direct drive-on access from the Trans-Canada Highway, as well as a regional railway and power grid four kilometers to the south. Additionally, the nearby town of Kapuskasing, with a population of 8,300, provides essential support services.

This strategic positioning ensures the Filion Project’s viability for cost-effective, year-round operations in an area poised for untapped discovery potential.

Latham Copper-Gold Project

Situated in British Columbia’s renowned Golden Triangle, the Latham Project spans a vast 689-square-kilometer district, offering immense potential for multiple major discoveries. Accessible year-round via Highway 37, just 20 kilometers south of the town of Dease Lake, the site is strategically located amidst established mining infrastructure, including the active Red Chris mine to the southeast and upcoming major porphyry projects at Schaft Creek and Galore Creek along-trend to the southwest.

Highlighted by the Gnat Pass copper-gold porphyry deposit dating back to the 1960s, the Latham Project presents a compelling opportunity for significant expansion and potential discovery. A non-compliant indicated resource at the Gnat Pass deposit includes 33 million tonnes at 0.39% copper, open beyond 200 meters vertical depth, alongside six drill-ready kilometer-scale copper-gold exploration targets.

Moreover, the Latham Project’s appeal corresponds to the region being an attractive destination for major asset acquisitions and takeovers. Recent transactions within a 40-kilometer radius include Newmont’s 2021 acquisition of the Saddle North copper-gold porphyry deposit for $311 million and Newcrest’s investment in the Red Chris copper-gold porphyry deposit in 2019 for $804 million, underscoring industry acknowledgment of the region’s potential.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 that the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Likewise, a report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Malcolm Dorsey, P.Geo., is President, CEO and Director of Torr Metals. He brings over a decade of expertise as a seasoned exploration geologist and project developer, having been pivotal in driving the success of numerous diverse projects across North, Central, and South America. His comprehensive background spans early-stage exploration through to resource development and project acquisitions. His academic credentials include an M.Sc. in Geology and Geophysics from the University of Calgary, where his research characterized the district-scale structural influences affecting copper and gold mineralizing events in western British Columbia. Prior to his current role, he served as Senior Geologist for Benchmark Metals, where his contributions were instrumental in advancing the company’s gold equivalent resource from approximately 80,000 ounces to a maiden resource estimate of 2.92 million ounces.

John Williamson, P. Geol., is Chairman and Director of Torr Metals. He is a mining executive and investor with more than 30 years of experience as a founder, promoter and leader in the formation, financing and operation of private and public companies with exploration and mining interests worldwide. On more than one occasion his team’s efforts have been recognized for excellence by being named to the TSX Venture 50. He holds a B.Sc. in Geology and is a registered Professional Geologist (P.Geol.) with the Association of Professional Engineers and Geoscientists (APEGA) and the Geological Association of Canada.

Torr Metals Inc. (TSX.V: TMET), closed Monday's trading session at $0.09, off by 14.2857%, on 500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $24.01/$31.90.

Recent News

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF)

The QualityStocks Daily Newsletter would like to spotlight Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF).

"Gold has value beyond its appreciated aesthetics; gold is a very unique precious metal," Forbes reports.

In its recent update to shareholders, Renforth Resources noted key progress in its gold-exploration efforts.

Findings "demonstrate the potential of our properties" and speak to "the immense opportunity ahead," notes CEO.

Long an essential component of a healthy global economy, gold has steadily increased in value since the turn of the century. Companies operating in gold exploration and mining, such as Renforth Resources (CSE: RFR) (OTCQB: RFHRF), play a key role in discovering and supplying gold. Renforth Resources recently strengthened its position in the gold space with an update on significant gold exploration advances at two of its properties (https://ibn.fm/TlV99).

Annovis Bio Inc. Overview

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly owned multi-commodity mineral properties in Canada. The company owns the Parbec gold deposit on the Cadillac Break in Quebec and is currently exploring the Parbec property to increase the gold resource and identify a location to strip and bulk sample from surface.

In addition, the company holds the Nixon Bartleman gold property in Ontario and is also engaged in developing its wholly owned Malartic Metals Package, Quebec’s newest polymetallic battery minerals district with several areas of mineralization, one of which is the nickel, cobalt, copper and zinc mineralized Victoria structure boasting approximately 20 kilometers of strike with surface mineralization, limited drilling, road access and hydroelectric power.

Renforth is well positioned in the heart of the Abitibi Greenstone belt, which straddles the Canadian Provinces of Ontario and Quebec, on both of the Cadillac-Larder Lake and Destor-Porcupine faults – the two main structures responsible for a belt endowed with more than 300 million ounces of gold (including production, M&I reserves and resources to date), making it one of the world’s most prospective gold regions.

The Canadian Malartic Mine, one of Canada’s largest gold mines, is adjacent to each of Renforth’s brownfield Malartic area properties, the Parbec open pit gold resource and the Malartic Metals Package, which, in addition to several known battery metals mineralized structures, also hosts gold within the Pontiac sediments, a very under-explored geological setting.

The company is headquartered in Pickering, Ontario.

Projects

Parbec Gold Deposit

Renforth’s 100% owned Parbec Gold Deposit contains a gold resource designed with an open pit to capitalize on Parbec’s surface mineralization. An MRE on the project, effective December 2019 and now considered by Renforth to be obsolete, is based upon approximately 28,000 meters of drilling which occurred between 2007 and 2019.

Renforth drilled 15,000 meters of new holes in 2020 and 2021 which were not included in the MRE, but which did extend the mineralization deeper within the MRE. The 2020-21 drilling is considered to have validated an additional 13,000 meters of historic drilling from 1986-93.

The validation occurs as 10% of the historic holes were redrilled, with results comparable to the historic results in terms of geology and gold values. Any future MRE calculated at Parbec will benefit from the inclusion of the new and historic drilling.

In addition to this, Renforth’s current structural interpretation on the location of, and controls on, the gold mineralization at Parbec is materially different than the geological model for the outdated MRE. For the first time, Renforth has mapped the Pontiac contact and interpreted a hinge fold interacting with the Cadillac Break and allowing the movement of gold enriched fluids, with mineralization plunging to the south, into the Pontiac.

It is worth noting that a structural control on the adjacent, and much larger, Canadian Malartic Mine is the Sladen Fault transiting into the Pontiac. Currently, Renforth is testing this interpretation with a soil survey designed to outline an area for stripping and bulk sampling within the Pontiac south of the Cadillac Break.

Malartic Metals Package

Renforth’s wholly owned approximately 300-square-kilometer Malartic Metals Package in Quebec’s mining heartland includes surface mineralization of battery metals nickel, cobalt, copper, zinc and silver in separate structures, as well as a copper/silver discovery and gold mineralization. Lithium is also present in anomalous amounts in the sediments, though the source has not yet been located.

The property was assembled commencing in 2020 by adding claims to Renforth’s existing Malartic West property by map staking. The goal was to acquire historic gold and base metal showings, as well as pronounced magnetic anomalies, joining several of the areas of discrete historic exploration into a district scale property with several areas of interest for battery metals and a greenfield copper/silver discovery. The property benefits from its location in an established mining community, roads on the property, rail just off the property and hydroelectric power lines crossing the property, making logistics simple and the cost to operate quite low.

This is the first time this property has been assembled as it is today and actively explored. A significant portion of the property has never been explored.

Market Overview

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In August 2024, the market price of gold was approximately $2,435 per ounce.

Management Team

Nicole Brewster is President and CEO of Renforth Resources. During her tenure she has reconstituted the company, developed a maiden mineral resource and sold a gold deposit. She is a native of the Toronto area and has been around the mining business nearly all her life, having been raised by a successful mineral exploration geologist who worked (and is still working) around the world as an entrepreneur and geoscientist.

Ms. Brewster worked summer jobs in various segments of the mining business, which led to her employment as a contractor working in the early days of the digitization of exploration data, 3D modeling and data visualization. After working in the capital markets for a time, she returned to the mineral exploration business as a partner in a successful private firm with several employees.

Renforth Resources Inc. (OTCQB: RFHRF), closed Monday's trading session at $0.0087, off by 16.3462%, on 23,600 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0068/$0.0241.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $1.71, up 3.6364%, on 895,942 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.60/$2250.00.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Monday's trading session at $0.0707, up 15.7119%, on 9,334 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0364/$0.1164.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Monday's trading session at $0.1278, up 9.4178%, on 23,013,248 volume. The average volume for the last 3 months is 13.98M and the stock's 52-week low/high is $0.0955/$6875.00.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Monday's trading session at $0.0391, up 59.5918%, on 10,500 volume. The average volume for the last 3 months is 10,815 and the stock's 52-week low/high is $0.0195/$0.2269.

Recent News

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.

 

Projects

Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Monday's trading session at $0.1007, up 2.7551%, on 78,521 volume. The average volume for the last 3 months is 48,139 and the stock's 52-week low/high is $0.047785/$0.1245.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.